Global equities traded higher during the first
3 weeks of the month but saw sharp decline
in the last week with MSCI ACWI ending the
month down 0.5% in January. This follows
strong returns in the previous two months
with December (+4.5%) and November
(+12.2%). European equities (SXXP -1.6%)
underperformed relative to their US peers
(SPX -1.1%) in January led by a weaker EUR
(-0.7%). VIX index was up 45% MoM to end
the month at 33.09 following an 11% gain in
December. Global growth outlook remains
for a modest Q1 slowdown to below-trend
due to the virus and lockdowns, but a sharp
acceleration from Q2 as economies reopen
and vaccines are deployed.
Covid-19 & Vaccine:
Globally, daily cases have
come down sharply off the peaks and daily
deaths too are showing signs of plateauing.
With vaccination pace picking up across several developed economies, the pace of vaccinations has now hit almost
5 million shots a day. Rapid immunization and reduction in infection rate is key to the expected global recovery in
the second half of CY22.